- Generic name
- Calcitriol
- Class
- Active vitamin D (1,25-dihydroxyvitamin D3)
- Mechanism
- Active vitamin D3 that stimulates intestinal calcium transport. Its benefit in renal bone disease appears to result from correcting hypocalcemia and secondary hyperparathyroidism.
- Used for
- Secondary hyperparathyroidism and associated metabolic bone disease in moderate-to-severe chronic renal failure before dialysis; Hypocalcemia and associated metabolic bone disease in chronic dialysis; Hypocalcemia in postsurgical or idiopathic hypoparathyroidism, or pseudohypoparathyroidism
- Common side effects
- Hypercalcemia; Weakness; Headache; Nausea
- Warnings
- Contraindicated in hypercalcemia or vitamin D toxicity; Keep calcium x phosphate product in range
- Interactions
- Cholestyramine; Phenytoin / phenobarbital; Thiazides
Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.
Read the source label ↗Label date: 20260715 · For learning, not clinical decisions. US label and brand information; always consult the current source.
Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.